**Question:** Which of the following drugs is primarily eliminated through acetylation, a phase II biotransformation process?

A. Paracetamol
B. Aspirin
C. N-acetylcysteine
D. Ibuprofen

**Core Concept:**
Phase II biotransformation processes involve the attachment of a functional group to the parent drug molecule, often to improve solubility, stability, or target specificity. Acetylation is a common phase II biotransformation process, where an acetyl group is added to the parent drug molecule. This process is typically carried out by the enzyme N-acetyltransferase (NAT).

**Why the Correct Answer is Right:**
Acetylation is the correct answer because the drug is primarily eliminated through this process. In this case, CYP enzymes (Cytochrome P450) primarily biotransform drugs through phase I biotransformation, which involves the breaking of chemical bonds. However, acetylation is a phase II biotransformation process, which modifies the parent drug molecule.

CYP enzymes are responsible for the primary biotransformation of drugs like Diclofenac (Drug D). In contrast, acetylation is involved in the biotransformation of Drug C (N-acetylcysteine) and Drug A (Paracetamol). Drug B (Aspirin) is primarily eliminated through COX (Cyclooxygenase) inhibition, not acetylation.

**Why Each Wrong Option is Incorrect:**

A. Paracetamol (Drug A) is primarily eliminated through CYP2E1-mediated oxidation, not acetylation.

B. Aspirin (Drug B) is primarily eliminated through COX (Cyclooxygenase) inhibition, not acetylation. Acetylation is involved in the biotransformation of Drug C (N-acetylcysteine) and Drug A (Paracetamol).

C. N-acetylcysteine (Drug C) is primarily eliminated through conjugation with glucuronide and sulfate, not acetylation. Acetylation is involved in the biotransformation of Drug B (Aspirin).

D. Ibuprofen (Drug D) is primarily eliminated through CYP-mediated oxidation, not acetylation. Acetylation is involved in the biotransformation of Drug C (N-acetylcysteine) and Drug A (Paracetamol).

**Clinical Pearls:**

1. Understanding the primary biotransformation pathways of drugs is crucial for predicting potential drug-drug interactions and selecting the appropriate drug for a patient with a specific condition. For example, paracetamol (Drug A) is commonly used in pain management due to its lack of significant CYP-mediated biotransformation, which reduces the risk of potential drug-drug interactions that might occur with drugs like ibuprofen (Drug D) or aspirin (Drug B).
2. N-acetylcysteine (Drug C) is often used in acetaminophen (Paracetamol) overdoses due to its